Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$255.65 - $303.1 $196,850 - $233,387
-770 Closed
0 $0
Q2 2020

Aug 12, 2020

SELL
$225.48 - $295.8 $338,220 - $443,700
-1,500 Reduced 66.08%
770 $224,000
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $144,833 - $179,662
725 Added 46.93%
2,270 $540,000
Q4 2019

Jan 14, 2020

BUY
$166.71 - $223.91 $257,566 - $345,940
1,545 New
1,545 $338,000
Q2 2019

Jul 31, 2019

SELL
$164.61 - $190.37 $2.49 Million - $2.88 Million
-15,110 Closed
0 $0
Q1 2019

Apr 30, 2019

BUY
$163.73 - $194.7 $372,485 - $442,942
2,275 Added 17.72%
15,110 $2.78 Million
Q4 2018

Feb 08, 2019

SELL
$151.91 - $192.21 $4.28 Million - $5.42 Million
-28,180 Reduced 68.71%
12,835 $2.13 Million
Q3 2018

Nov 13, 2018

BUY
$167.73 - $192.74 $465,450 - $534,853
2,775 Added 7.26%
41,015 $7.91 Million
Q2 2018

Aug 13, 2018

SELL
$145.72 - $169.96 $461,203 - $537,923
-3,165 Reduced 7.64%
38,240 $6.5 Million
Q1 2018

May 14, 2018

SELL
$151.6 - $177.13 $92,627 - $108,226
-611 Reduced 1.45%
41,405 $6.75 Million
Q4 2017

Feb 13, 2018

BUY
$137.28 - $155.55 $5.58 Million - $6.32 Million
40,640 Added 2953.49%
42,016 $6.3 Million
Q3 2017

Oct 30, 2017

BUY
$148.13 - $162.24 $203,826 - $223,242
1,376
1,376 $209,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $120B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Tocqueville Asset Management L.P. Portfolio

Follow Tocqueville Asset Management L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Tocqueville Asset Management L.P., based on Form 13F filings with the SEC.

News

Stay updated on Tocqueville Asset Management L.P. with notifications on news.